Remove Allergies Remove Clinical Research Remove Dermatology Remove In-Vitro
article thumbnail

Clinical Catch-Up: January 18-22 | BioSpace

The Pharma Data

It inked a deal with the National Institute of Allergy and Infectious Diseases (NIAID) to launch a Phase I trial. It will be run through the NIAID-supported Infectious Diseases Clinical Research Consortium (IDCRC), with support from the Bill & Melinda Gates Foundation. It also has robust antimicrobial properties.

Trials 52